Thorough QT (TQT) Study to Evaluate the Effect of LC350189 on Cardiac Repolarization in Healthy Male and Female Subjects

NCT04966325 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperuricemia
Gout
Qt Interval, Variation in

Interventions

DRUG: LC350189 200mg
DRUG: Placebo
DRUG: Moxifloxacin 400mg
DRUG: LC350189 600mg

Sponsor

LG Chem